The relationship between serum adiponectin, tumor necrosis factor-alpha, leptin levels and insulin sensitivity in childhood and adolescent obesity: Adiponectin is a marker of metabolic syndrome

JCRPE Journal of Clinical Research in Pediatric Endocrinology

Volumn 1, Issue 5, 2009, Pages 233-239

  Alikaşifoǧlu, Ayfer ^a   Gönç, E Nazli ^a   Özön, Z Alev ^a   Şen, Yaşar ^a   Kandemir, Nurgün ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Adiponectin; Children; Metabolic syndrome; Obesity

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; HIGH DENSITY LIPOPROTEIN; INSULIN; LEPTIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ARTICLE; BODY MASS; CHILD; CHILDHOOD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GLUCOSE TOLERANCE; GROUPS BY AGE; HORMONE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SEX DIFFERENCE;

ADIPONECTIN; ADOLESCENT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; LIPIDS; MALE; METABOLIC SYNDROME X; OBESITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953417982     PISSN: 13085727     EISSN: 13085735     Source Type: Journal    
DOI: 10.4274/jcrpe.v1i5.233     Document Type: Article

References (40)

1. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical ecrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83. [Abstract] / [Full Text] / [PDF]
2. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, Chen CL, Tai TY, Chuang LM. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001;86: 3815-3819. [Abstract] / [Full Text] / [PDF]
3. Stefan N, Bunt JC, Salbe AD, Funahashi T, Matsuzawa Y, Tataranni PA. Plasma adiponectin concentrations in children: relationships with obesity and insulinemia. J Clin Endocrinol Metab 2002;87:4652-4656. [Abstract] / [Full Text] / [PDF]
4. Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003;148:293-300. [Abstract] / [PDF]
5. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P & Kadowaki T. The-fat derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-946. [Abstract] / [Full Text] / [PDF]
6. Gil-Campos M, Canete R, Gil A. Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 2004;23:963-974. [Abstract] / [Full Text] / [PDF]
7. Matsuzawa Y. Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease. Atheroscler 2005;6(suppl):7-14. [Abstract] / [Full Text] / [PDF]
8. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa H, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20:1595-1599. [Abstract] / [Full Text] / [PDF]
9. Bacha F, Saad R, Gungor N, Arslanian SA. Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care 2004;27:547-552. [Abstract] / [Full Text]
10. Bacha F, Saad R, Gungor N, Arslanian SA. Does adiponectin explain the lower insulin sensitivity and hyperinsulinemia of African-American children? Pediatr Diabet 2005;6:100-102. [Abstract] / [PDF]
11. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB & Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002;8:1288-1295. [Abstract] / [Full Text]
12. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. Adiponectin, an adipocyte-derived plasma protein, inhibit endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000;102:1296-1301. [Abstract] / [Full Text]
13. Okamoto Y, Arita Y, Nishida M, Muraguchi M, Ouchi N, Takahashi M, Igura T, Inui Y, Kihara S, Nakamura T, Yamashita S, Miyagawa J, Funahashi T, Matsuzawa Y. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 2000;32:47-50. [Abstract] / [Full Text] / [PDF]
14. Rothenbacher D, Brenner H, Marz W, Koenig W. Adiponectin, risk of coronory artery disease and correlations with cardiovascular risk markers. Eur Heart J 2005;26:1640-1646. [Abstract] / [Full Text] / [PDF]
15. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004;291:1730-1737. [Abstract] / [Full Text] / [PDF]
16. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000;320:1240-1243. [Abstract] / [Full Text] / [PDF]
17. Viner RM, Segal TY, Lichtarowicz-Krynska E, Hindmarsh P. Prevalence of the insulin resistance syndrome in obesity. Arch Dis Child 2005;90:10-14. [Abstract] / [Full Text]
18. Widhalm K. Hyperlipoproteinemias in children and adolescents. In: Lifshitz F (ed). Pediatric Endocrinology. 4th edition. New York, Marcel Dekker, Inc; 2003:859-864.
19. Tumer N, Yalcinkaya F, Ince E, Ekim M, Köse K, Çakar N, Kara N, Özkaya N, Ensari C, Önder S. Blood pressure nomograms for children and adolescents in Turkey. Pediatr Nephrol 1999;13:438-443. [Abstract]
20. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose as an endocrine and secretory organ. Proceedings of the Nutrition Society 2001;60:329-339. [Abstract]
21. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001;50:2094-2099. [Abstract] / [Full Text] / [PDF]
22. Lihn AS, Pedersen SB, Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 2005;6:13-21. [Abstract] / [Full Text] / [PDF]
23. Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, Olefsky JM. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 2002;51:2968-2974. [Abstract] / [Full Text] / [PDF]
24. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-1935. [Abstract] / [Full Text] / [PDF]
25. Spranger J, Kroke A, Möhlig M, Bergmann MM, Ristow M, Boeing H, Pfeiffer AFH. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003;361: 226-228. [Abstract] / [Full Text] / [PDF]
26. Yamamoto Y, Hirose H, Saito I, Motowo T, Matsuo T, Koichi M, Yasunori O, Tatsuya I, Kanako N, Takao Sl. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci 2002;103:137-142. [Abstract] / [PDF]
27. Bush NC, Darnell BE, Oster RA, Goran MI, Gower BA. Adiponectin is lower among African Americans and is independently related to insulin sensitivity in children and adolescents. Diabetes 2005;54:2772-2778. [Abstract] / [Full Text] / [PDF]
28. Weiss R, Dufour S, Groszmann A, Petersen K, Dziura J, Taksali SE, Shulman G, Caprio S. Low adiponectin levels in adolescent obesity: a marker of increased intramyocellular lipid accumulation. J Clin Endocrinol Metab 2003;88:2014-2018. [Abstract] / [Full Text] / [PDF]
29. Asayama K, Hayashibe H, Dobashi K, Uchida N, Nakane T, Kodera K, Shirahata A, Taniyama M. Decrease in serum adioponectin levels due to obesity and visceral fat accumulation in children Obes Res 2003;11:1072-1079. [Full Text] / [PDF]
30. Cruz M, Garcia-Macedo R, Garcio-Valerio Y, Gutierrez M, Medina-Navarro R, Duran G, Wacher N, Kumate J. Low adiponectin levels predict type 2 diabetes in Mexican children. Diabetes Care 2004;27:1451-1453. [Full Text] / [PDF]
31. Punthakee Z, Delvin EE, O'Lougghlin J, Paradis G, Levy E, Platt RW, Lambert M. Adiponectin, adiposity, and insulin resistance in children and adolescents. J Clin Endocrinol Metab 2006;91:2119-2125. [Abstract] / [Full Text] / [PDF]
32. Araki S, Dobashi K, Kubo K, Asayama K, Shirahata A. High molecular weight, rather than total, adiponectin levels better reflect metabolic abnormalities associated with childhood obesity. J Clin Endocrinol Metab 2006;91:5113-5116. [Abstract] / [Full Text] / [PDF]
33. Matsubara M, Maruoka S, Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 2002;87:2764-2769. [Abstract] / [PDF]
34. Weiss R, Dziura J, Burgert S, Tamborlane WV, Taksali SE, Yeckel C, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004;350:2362-2374. [Abstract] / [Full Text] / [PDF]
35. Winer JC, Zern TL, Taksali SE, Dziura J, Cali AMG, Wollschlager M, Seyal AA, Weiss R, Burgert TS, Caprio S. Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome. J Clin Endocrinol Metab 2006;91:4415-4423. [Abstract] / [Full Text] / [PDF]
36. Ogawa Y, Kikuchi T, Nagasaki K, Hiura M, Tanaka Y, Uchiyama M. Usefulness of serum adiponectin level as a diagnostic marker of metabolic syndrome in obese Japanese children. Hypertens Res 2005;28:51-57. [Abstract] / [PDF]
37. Gilardini R, McTernan PG, Girola A, da Silva NF, Alberti L, Kumar S, Invitti C. Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents. Atherosclerosis 2006; 189:401-407. [Abstract] / [Full Text] / [PDF]
38. Matzusawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Atheroscler Thromb Vasc Biol 2004;24:29-33. [Abstract] / [Full Text] / [PDF]
39. Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, Nagai M, Matsuzawa Y, Funahashi T. Adiponectin is as a biomarker of the metabolic syndrome. Circ J 2004;68:975-81. [Abstract] / [PDF]
40. Dandona P, Alijada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005;111:1448-1454. [Abstract] / [Full Text] / [PDF]